Clinical Trial Update: Brigatinib Before Brain Irradiation Trial (B3i Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial update for brigatinib before brain irradiation in patients with brain metastases and lung cancer has been terminated; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Lung Cancer

Drugs mentioned

• Brigatinib (brigatinib)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Brain Metastases, Lung Cancer | Phase 2 | Status: TERMINATED | Results posted: 2022-10-24